Cargando…
Potent Dual Polymerase/Exonuclease Inhibitory Activities of Antioxidant Aminothiadiazoles Against the COVID-19 Omicron Virus: A Promising In Silico/In Vitro Repositioning Research Study
Recently, natural and synthetic nitrogenous heterocyclic antivirals topped the scene as first choices for the treatment of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and their accompanying disease, the coronavirus disease 2019 (COVID-19). Meanwhile, the mysterious ev...
Autores principales: | Rabie, Amgad M., Eltayb, Wafa A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9870775/ https://www.ncbi.nlm.nih.gov/pubmed/36690820 http://dx.doi.org/10.1007/s12033-022-00551-8 |
Ejemplares similares
-
Strong Dual Antipolymerase/Antiexonuclease Actions of Some Aminothiadiazole Antioxidants: A Promising In-Silico/In-Vitro Repurposing Research Study against the COVID-19 Omicron Virus (B.1.1.529.3 Lineage)
por: Rabie, Amgad M., et al.
Publicado: (2023) -
Efficacious Preclinical Repurposing of the Nucleoside
Analogue Didanosine against COVID-19 Polymerase and Exonuclease
por: Rabie, Amgad M.
Publicado: (2022) -
Novel Investigational
Anti-SARS-CoV-2 Agent
Ensitrelvir “S-217622”: A Very Promising Potential Universal
Broad-Spectrum Antiviral at the Therapeutic Frontline of Coronavirus
Species
por: Eltayb, Wafa A., et al.
Publicado: (2023) -
Dual computational and biological assessment of some promising nucleoside analogs against the COVID-19-Omicron variant
por: Abdalla, Mohnad, et al.
Publicado: (2023) -
Potent Inhibitory Activities of the Adenosine Analogue Cordycepin on SARS-CoV-2
Replication
por: Rabie, Amgad M.
Publicado: (2022)